期刊文献+

冠状动脉旁路移植术和药物支架植入术远期疗效的比较 被引量:6

Long-term outcomes of patients with angina after undergoing coronary artery bypass grafts or percutaneous coronary intervention
下载PDF
导出
摘要 目的比较冠心病患者非药物治疗手段冠状动脉旁路移植术(CABG)和经皮冠状动脉介入治疗(PCI)术后的桥血管和支架的再通率。方法CABG术后和药物支架植入术后再次出现心绞痛症状的冠心病患者各40例,其年龄、性别、心肌梗死、高血压、高脂血症、心功能不全、脑卒中、药物治疗病史具有可比性。通过冠状动脉造影术比较两组患者的桥血管和药物支架的效率和寿命的远期效果。结果与行CABG患者的桥血管比较,行PCI患者的药物支架远期狭窄或者闭塞率降低34.3%。与行CABG患者的左乳内动脉(LIMA)桥血管比较,行PCI患者的左前降支的药物支架远期狭窄或者闭塞率降低14.8%。与行CABG患者的左回旋支和右冠状动脉静脉桥血管比较,行PCI患者的左回旋支以及右冠状动脉的药物支架远期狭窄或者闭塞率降低49.8%。结论冠状动脉药物支架植入术的远期通畅率较CABG明显增高,冠状动脉药物支架植入术的药物支架的效率和寿命要优于CABG的桥血管。 Objective To assess the long-term outcomes of patients with coronary atherosclerotic heart disease undergoing coronary artery bypass grafts (CABG) and percutaneous coronary intervention (PCI). Methods Patients with coronary heart disease undergoing CABG or PCI and suffering angina again, were enrolled, with 40 in CABG group and PCI group respectively. Age, gender, myocardial infarction, hypertension, hyperlipidemia, heart failure, stroke and medicinal history were matched between two groups. The long-term efficiency was compared between the two groups by coronary angiography. Results Compared with CABG group, the long-term stenosis and blocking rate declined by 34.3% in PCI group. Compared with bypass artery of the left internal mammary artery of patients in CABG group, the long-term stenosis and blocking rate of the left anterior descending branches declined by 14.8% in PCI group. Compared with bypass vein of the left circumflex branches and the right coronary of patients in CABG group, the long-term stenosis and blocking rate of the left circumflex branches and the right coronary declined by 49.8% in PCI group. Conclusion The long-term revascularization rate is higher in PCI group than in CABG group. The drug stent in PCI is superior to bypass artery in CABG.
出处 《中华老年多器官疾病杂志》 2012年第10期791-794,共4页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 冠状动脉旁路移植术 经皮冠状动脉介入治疗术 冠状动脉造影术 桥血管 药物支架 远期效果 coronary artery bypass grafts pereutaneous coronary intervention coronary angiography bypass artery drug stent long-term outcome
  • 相关文献

参考文献11

  • 1Kawecki D, Morawiec B, Fudal M, et al. Comparison of coronary artery bypass grafting with percutaneous coronary intervention for unprotected left main coronary artery disease[J]. Yonsei Med J, 2012, 53(1): 58-67.
  • 2Briguori C, Airoldi F, Chieffo A, et al. Elective versus provisional intraaortic balloon pumping in unprotected left main stenting[J]. Am Heart J, 2006, 152(3): 565-572.
  • 3Ropers D, Pohle FK, Kuettner A, et al. Diagnostic accuracy of noninvasive coronary angiography in patients atier bypass surgery using 64-slice spiral computed tomography with 330-ms gantry rotation[J]. Circulation, 2006, 114(22): 2334-2341.
  • 4Eifert S, Oberhoffer M, Wintersperger B, et al. Arterial T-graft in coronary surgery: comparison of selective coronary angiography and multi-slice computed tomography[J]. Thorac Cardiovasc Surg, 2007, 55(3): 173-176.
  • 5Jones WS, Patel MR, Holleran SA, et al. Trends in the use of diagnostic coronary angiography, percutaneous coronary intervention, and coronary artery bypass graft surgery across North Carolina[J]. Am Heart J, 2011,162(5): 932-937.
  • 6Olenchock SA, Karmapaliotis D, Gibson WJ, et al. Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters[J]. Ann Thorac Surg, 2008, 85(2): 520-524.
  • 7Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: classification and implicationfor long-term outcomes[J]. Circulation, 1999, 100(18): 1872-1878.
  • 8Sabik JF 3rd, Blackstone EH. Coronary artery bypass graft patency and competitive flow[J]. J Am Coil Cardiol, 2008, 51(2): 126-128.
  • 9Speidel CM, Thornton JD, Meng YY, et al. Procoagulant activity on injured arteries and associated thrombi is mediated primarily by the complex of tissue factor and factor Vl[a[J]. Coron Artery Dis, 1996, 7(1): 57-62.
  • 10Pintucci G, Froum S, Pinnell J, et al. Trophic effects of platelets on cultured endothelial cells are mediated by platelet-associated fibroblast growth factor-2(FGF-2) and vascular endothelial growth factor (VEGF)[J]. Thromb Haemost, 2002, 88(5): 834-842.

同被引文献37

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部